ID   KFrb
AC   CVCL_M714
DR   Wikidata; Q54899830
RX   PubMed=7844449;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F843 ! KF-1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
RX   PubMed=7844449;
RA   Ishii, Kenji
RA   Kita, Tsunekazu
RA   Kudo, Kazuya
RA   Hisano, Atsushi
RA   Hirata, Junko
RA   Imaizumi, Eiji
RA   Tode, Takehiko
RA   Kikuchi, Yoshihiro
RA   Nagata, Ichiro
RT   "Circumvention of cisplatin resistant ovarian cancer cells by
RT   antiestrogens.";
RL   Nihon Sanka Fujinka Gakkai Zasshi 47:19-26(1995).
//